ZoomForward22
Spotlight on ZoomForward22 E-Posters
Present your latest research and clinical work by submitting an abstract to ZoomForward22. E-posters will form an important part of ZoomForward22, taking on a feature role in the congress programme and on the virtual platform. We will host daily moderated e-poster discussion sessions and will showcase the highest scoring abstract authors with video interviews. All abstracts and suggestions must adhere to the EASO person first language guidelines. The deadline for receipt of abstracts and suggestions is 14 January 2022.
Symposium Suggestions
ZoomForward22 also welcomes your suggestions for full interactive symposia, which should be proposed in the format outlined below All text in symposium suggestions must adhere to the EASO person first language guidelines. The deadline for receipt of symposium suggestions is 14 January 2022.
Abstract Submission
Abstracts accepted for e-posters will be published as a supplement to Obesity Facts, the European Journal of Obesity. Remember that all abstract submissions must use person first language. 14 January 2022 is the submission deadline.
Please ensure that your text is uploaded to the appropriate section of the ZoomForward22 submission system. Note that EASO encourages full disclosure of all relevant sources of funding in relation to abstracts submitted to this conference. If you wish to disclose sources of funding or any potential conflicts of interest, please do so briefly in the footer of the abstract, as shown.
Author names and affiliations will be requested separately during the submission process and should not be entered in the abstract text section.
Arial 10 font bold, left aligned, maximum 200 characters. For example:
Prevention of obesity in school age children
Arial 10 font, left aligned, maximum 3200 characters including spaces (excluding title but including references) – please note that word counts will be checked and abstracts that do not adhere to these guidelines will be automatically rejected.
Example abstract:
Metabolic Syndrome may be associated to some cancers
Introduction:
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Methods:
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Results:
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Conclusion:
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo. Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.